SIRT6在肺部疾病中的研究进展：从基础到临床的全面综述
Research Progress on SIRT6 in Pulmonary Diseases: A Comprehensive Review from Bench to Bedside
DOI: 10.12677/acrvm.2025.133003, PDF,    科研立项经费支持
作者: 曹 晶*, 李 勇, 陈 斌, 刘文广, 喻廷凤：益阳市中心医院呼吸内科，湖南 益阳
关键词: SIRT6；肺部疾病；诊断；治疗；SIRT6； Pulmonary Diseases； Diagnosis； Prognosis
摘要: 本文全面综述了SIRT6在肺部疾病中的研究进展，涵盖基础理论、流行病学、病理机制、诊断、治疗等多个方面。在基础理论部分，阐述了SIRT6的分子结构与功能及其在肺部疾病中的生物学作用和相关信号通路。流行病学研究分析了SIRT6表达水平与肺部疾病的关联、不同人群中的发病率及遗传易感性。病理机制方面，探讨了SIRT6在肺纤维化、慢性阻塞性肺疾病和肺癌发展中的作用。诊断应用上，评估了SIRT6作为生物标志物的潜力、相关诊断技术现状及早期检测前景。治疗策略包括SIRT6靶向治疗进展、激活剂的临床试验及与现有治疗方法的联合应用。同时，讨论了SIRT6研究中的争议与挑战，并对未来研究方向进行了展望。这些研究为深入理解肺部疾病的发病机制及开发基于SIRT6的治疗策略提供了重要参考。
Abstract: This comprehensive review systematically summarizes research advances on SIRT6 in pulmonary diseases, encompassing fundamental theories, epidemiological findings, pathological mechanisms, diagnostic approaches, and therapeutic strategies. The theoretical foundations section elucidates SIRT6’s molecular structure and functions, along with its biological roles and associated signaling pathways in pulmonary pathologies. Epidemiological investigations analyze correlations between SIRT6 expression levels and pulmonary diseases, disease incidence across populations, and genetic susceptibility factors. Regarding pathological mechanisms, the review examines SIRT6’s involvement in pulmonary fibrosis, chronic obstructive pulmonary disease (COPD), and lung cancer progression. Diagnostic applications evaluate SIRT6’s potential as a biomarker, current diagnostic technologies, and prospects for early detection. Therapeutic approaches include recent advances in SIRT6-targeted interventions, clinical trials of activators, and combination strategies with existing treatments. The review also addresses current controversies and challenges in SIRT6 research, while proposing future research directions. These collective findings provide crucial references for understanding disease pathogenesis and developing SIRT6-based therapeutic approaches for pulmonary disorders.
文章引用：曹晶, 李勇, 陈斌, 刘文广, 喻廷凤. SIRT6在肺部疾病中的研究进展：从基础到临床的全面综述[J]. 亚洲心脑血管病例研究, 2025, 13(3): 19-29. https://doi.org/10.12677/acrvm.2025.133003

参考文献

[1] Frye, R.A. (2000) Phylogenetic Classification of Prokaryotic and Eukaryotic Sir2-Like Proteins. Biochemical and Biophysical Research Communications, 273, 793-798. [Google Scholar] [CrossRef] [PubMed]
[2] Farber, B.F., Broome, C.V. and Hopkins, C.C. (1984) Fulminant Hospital-Acquired Toxic Shock Syndrome. The American Journal of Medicine, 77, 331-332. [Google Scholar] [CrossRef] [PubMed]
[3] Li, Y., Jin, J. and Wang, Y. (2022) SIRT6 Widely Regulates Aging, Immunity, and Cancer. Frontiers in Oncology, 12, Article ID: 861334. [Google Scholar] [CrossRef] [PubMed]
[4] Akter, R., Afrose, A., Rahman, M.R., Chowdhury, R., Nirzhor, S.S.R., Khan, R.I., et al. (2021) A Comprehensive Analysis into the Therapeutic Application of Natural Products as SIRT6 Modulators in Alzheimer’s Disease, Aging, Cancer, Inflammation, and Diabetes. International Journal of Molecular Sciences, 22, Article 4180. [Google Scholar] [CrossRef] [PubMed]
[5] Bai, L., Lin, G., Sun, L., Liu, Y., Huang, X., Cao, C., et al. (2016) Upregulation of SIRT6 Predicts Poor Prognosis and Promotes Metastasis of Non-Small Cell Lung Cancer via the ERK1/2/MMP9 Pathway. Oncotarget, 7, 40377-40386. [Google Scholar] [CrossRef] [PubMed]
[6] Wawrzyniak, P., Wawrzyniak, M., Wanke, K., Sokolowska, M., Bendelja, K., Rückert, B., et al. (2017) Regulation of Bronchial Epithelial Barrier Integrity by Type 2 Cytokines and Histone Deacetylases in Asthmatic Patients. Journal of Allergy and Clinical Immunology, 139, 93-103. [Google Scholar] [CrossRef] [PubMed]
[7] 李昊龙, 赖天文, 吴斌. SIRT6在呼吸系统疾病中的作用研究进展[J]. 中华全科医学, 2019, 17(6): 1008-1013.
[8] Pan, P.W., Feldman, J.L., Devries, M.K., Dong, A., Edwards, A.M. and Denu, J.M. (2011) Structure and Biochemical Functions of Sirt6. Journal of Biological Chemistry, 286, 14575-14587. [Google Scholar] [CrossRef] [PubMed]
[9] Tennen, R.I., Berber, E. and Chua, K.F. (2010) Functional Dissection of SIRT6: Identification of Domains That Regulate Histone Deacetylase Activity and Chromatin Localization. Mechanisms of Ageing and Development, 131, 185-192. [Google Scholar] [CrossRef] [PubMed]
[10] Peng, L., Qian, M., Liu, Z., Tang, X., Sun, J., Jiang, Y., et al. (2020) Deacetylase-Independent Function of SIRT6 Couples GATA4 Transcription Factor and Epigenetic Activation against Cardiomyocyte Apoptosis. Nucleic Acids Research, 48, 4992-5005. [Google Scholar] [CrossRef] [PubMed]
[11] Liu, X., Ren, S., Li, Z., Hao, D., Zhao, X., Zhang, Z., et al. (2023) SIRT6 Mediates Antioxidative Functions by Increasing Nrf2 Abundance. Experimental Cell Research, 422, Article 113409. [Google Scholar] [CrossRef] [PubMed]
[12] Naiman, S., Huynh, F.K., Gil, R., Glick, Y., Shahar, Y., Touitou, N., et al. (2019) SIRT6 Promotes Hepatic Beta-Oxidation via Activation of PPARα. Cell Reports, 29, 4127-4143.E8. [Google Scholar] [CrossRef] [PubMed]
[13] Yang, J. and Chen, X. (2023) SIRT6 Attenuates LPS‐Induced Inflammation and Apoptosis of Lung Epithelial Cells in Acute Lung Injury through ACE2/STAT3/PIM1 Signaling. Immunity, Inflammation and Disease, 11, e809. [Google Scholar] [CrossRef] [PubMed]
[14] Han, Z., Liu, L., Liu, Y., et al. (2014) Sirtuin SIRT6 Suppresses Cell Proliferation through Inhibition of Twist1 Expression in Non-Small Cell Lung Cancer. International Journal of Clinical and Experimental Pathology, 7, 4774-4781.
[15] You, Q., Wang, J., Yu, Y., Li, F., Meng, L., Chen, M., et al. (2022) The Histone Deacetylase SIRT6 Promotes Glycolysis through the HIF-1α/HK2 Signaling Axis and Induces Erlotinib Resistance in Non-Small Cell Lung Cancer. Apoptosis, 27, 883-898. [Google Scholar] [CrossRef] [PubMed]
[16] He, J., Yu, C., Shen, Y., Huang, J., Zhou, Y., Gu, J., et al. (2023) Sirtuin 6 Ameliorates Bleomycin‐Induced Pulmonary Fibrosis via Activation of Lipid Catabolism. Journal of Cellular Physiology, 239, e31027. [Google Scholar] [CrossRef] [PubMed]
[17] Xiong, L., Tan, B., Lei, X., Zhang, B., Li, W., Liu, D., et al. (2021) SIRT6 through PI3K/Akt/mTOR Signaling Pathway to Enhance Radiosensitivity of Non‐Small Cell Lung Cancer and Inhibit Tumor Progression. IUBMB Life, 73, 1092-1102. [Google Scholar] [CrossRef] [PubMed]
[18] Takasaka, N., Araya, J., Hara, H., Ito, S., Kobayashi, K., Kurita, Y., et al. (2014) Autophagy Induction by SIRT6 through Attenuation of Insulin-Like Growth Factor Signaling Is Involved in the Regulation of Human Bronchial Epithelial Cell Senescence. The Journal of Immunology, 192, 958-968. [Google Scholar] [CrossRef] [PubMed]
[19] Azuma, Y., Yokobori, T., Mogi, A., Altan, B., Yajima, T., Kosaka, T., et al. (2015) SIRT6 Expression Is Associated with Poor Prognosis and Chemosensitivity in Patients with Non‐Small Cell Lung Cancer. Journal of Surgical Oncology, 112, 231-237. [Google Scholar] [CrossRef] [PubMed]
[20] Zhu, B., Yan, Y., Shao, B., Tian, L. and Zhou, W. (2018) Downregulation of SIRT6 Is Associated with Poor Prognosis in Patients with Non-Small Cell Lung Cancer. Journal of International Medical Research, 46, 1517-1527. [Google Scholar] [CrossRef] [PubMed]
[21] Wang, J., Luo, J., Rotili, D., Mai, A., Steegborn, C., Xu, S., et al. (2024) SIRT6 Protects against Lipopolysaccharide-Induced Inflammation in Human Pulmonary Lung Microvascular Endothelial Cells. Inflammation, 47, 323-332. Https://Doi.Org/10.1007/S10753-023-01911-5
[22] Guo, Y., Gong, Y., Shi, G., Yang, K., Pan, C., Li, M., et al. (2012) Single-Nucleotide Polymorphisms in the TSPYL-4 and NT5DC1 Genes Are Associated with Susceptibility to Chronic Obstructive Pulmonary Disease. Molecular Medicine Reports, 6, 631-638. [Google Scholar] [CrossRef] [PubMed]
[23] Clemenceau, A., Boucherat, O., Landry-Truchon, K., Lamontagne, M., Biardel, S., Joubert, P., et al. (2018) Lung Cancer Susceptibility Genetic Variants Modulate HOXB2 Expression in the Lung. The International Journal of Developmental Biology, 62, 857-864. [Google Scholar] [CrossRef] [PubMed]
[24] Chen, P., Tian, K., Tu, W., Zhang, Q., Han, L. and Zhou, X. (2019) Sirtuin 6 Inhibits MWCNTs-Induced Epithelial-Mesenchymal Transition in Human Bronchial Epithelial Cells via Inactivating TGF-β1/Smad2 Signaling Pathway. Toxicology and Applied Pharmacology, 374, 1-10. [Google Scholar] [CrossRef] [PubMed]
[25] Tao, L., Zhang, Q., Liu, L., Wang, K., Wang, J., Liu, X., et al. (2024) Inhibition of AhR Disrupts Intestinal Epithelial Barrier and Induces Intestinal Injury by Activating NF‐κB in COPD. The FASEB Journal, 38, e70256. [Google Scholar] [CrossRef] [PubMed]
[26] Han, L.L., Jia, L.J. and Zan, Y. (2020) Long Intergenic Noncoding RNA smad7 (Linc-smad7) Promotes the Epithelial-Mesenchymal TRANSITION of HCC by Targeting the miR-125b/SIRT6 Axis. Cancer Medicine, 9, 9123-9137. [Google Scholar] [CrossRef] [PubMed]
[27] Zhao, K., Zheng, M., Su, Z., Ghosh, S., Zhang, C., Zhong, W., et al. (2023) MOF-Mediated Acetylation of SIRT6 Disrupts SIRT6-FOXA2 Interaction and Represses SIRT6 Tumor-Suppressive Function by Upregulating ZEB2 in NSCLC. Cell Reports, 42, Article 112939. [Google Scholar] [CrossRef] [PubMed]
[28] Chen, X., Sun, W., Huang, S., Zhang, H., Lin, G., Li, H., et al. (2020) Discovery of Potent Small-Molecule SIRT6 Activators: Structure-Activity Relationship and Anti-Pancreatic Ductal Adenocarcinoma Activity. Journal of Medicinal Chemistry, 63, 10474-10495. [Google Scholar] [CrossRef] [PubMed]
[29] Krishnamoorthy, V. and Vilwanathan, R. (2020) Silencing Sirtuin 6 Induces Cell Cycle Arrest and Apoptosis in Non-Small Cell Lung Cancer Cell Lines. Genomics, 112, 3703-3712. [Google Scholar] [CrossRef] [PubMed]
[30] Feng, S., Li, Y., Huang, H., Huang, H., Duan, Y., Yuan, Z., et al. (2023) Isoorientin Reverses Lung Cancer Drug Resistance by Promoting Ferroptosis via the SIRT6/Nrf2/GPX4 Signaling Pathway. European Journal of Pharmacology, 954, Article 175853. [Google Scholar] [CrossRef] [PubMed]
[31] Yu, F., Gong, Z., Li, Y., Naseem, D.F., Li, C., Wen, M., et al. (2025) Association of SIRT6 Expression with Risk of Pneumonitis Induced by Radiotherapy in Cancer Patients. Molecular Carcinogenesis, 64, 1104-1118. [Google Scholar] [CrossRef] [PubMed]
[32] Liu, M., Liang, K., Zhen, J., Zhou, M., Wang, X., Wang, Z., et al. (2017) SIRT6 Deficiency Exacerbates Podocyte Injury and Proteinuria through Targeting Notch Signaling. Nature Communications, 8, Article No. 413. [Google Scholar] [CrossRef] [PubMed]

为你推荐